Prostate Cancer - Results from #19660

Physical functioning for prostate health - Abstract November 3, 2014

Docetaxel with or without zoledronic acid for castration-resistant prostate cancer - Abstract November 3, 2014

ASCO endorses AUA/ASTRO guideline on adjuvant and salvage radiotherapy after prostatectomy November 3, 2014

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer - Abstract November 1, 2014

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase 3 metastatic castration resistant prostate cancer trial - Abstract November 1, 2014

Poor glycemic control is associated with reduced prostate-specific antigen concentrations in men with type 1 diabetes - Abstract November 1, 2014

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan - Abstract November 1, 2014

Transperineal in-bore 3-T MR imaging-guided prostate biopsy: A prospective clinical observational study - Abstract November 1, 2014

Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: A SEER-based study - Abstract October 31, 2014

Achievements and perspectives in prostate cancer phase 3 trials from genitourinary research groups in Europe: Introducing the Prostate Cancer Consortium in Europe - Abstract October 31, 2014

Recommendations by the Canadian Task Force on Preventive Health Care on screening for prostate cancer with the prostate-specific antigen test October 31, 2014

Bone targeted treatment in prostate cancer - Abstract October 31, 2014

Nodal occult metastases in intermediate- and high-risk prostate cancer patients detected using serial section, immunohistochemistry, and real-time reverse transcriptase polymerase chain reaction: - Abstract October 30, 2014

Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer - Abstract October 30, 2014

Five year prostate-specific antigen outcomes after caesium prostate brachytherapy - Abstract October 30, 2014

Functional MRI in prostate cancer detection - Abstract October 30, 2014

Clinical (non-histological) diagnosis of advanced prostate cancer: Evaluation of treatment outcome after androgen deprivation therapy - Abstract October 30, 2014

Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery - Abstract October 30, 2014

Hypofractionated IMRT of the prostate bed after radical prostatectomy: Acute toxicity in the PRIAMOS-1 trial - Abstract October 30, 2014

Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: Multicenter experience in Turkey including 1,499 patients - Abstract October 30, 2014

Page 984 of 1447